Eaton Vance Management Corcept Therapeutics Inc Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Eaton Vance Management holds 100,000 shares of CORT stock, worth $5.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,000

Previous 100,165 0.16%

Holding current value

$5.86 Million

Previous $2.38 Million 7.64%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $4,075 - $4,804	-165 Reduced 0.16%	100,000 $2.56 Million
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $42,701 - $62,339	-2,464 Reduced 2.4%	100,165 $2.38 Million
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $18,860 - $28,764	1,141 Added 1.12%	102,629 $2.31 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $3,864 - $5,274	226 Added 0.22%	101,488 $1.98 Million
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $2,204 - $2,523	-112 Reduced 0.11%	101,262 $1.97 Million
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $11,223 - $13,729	562 Added 0.56%	101,374 $2.23 Million
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $8,973 - $11,673	382 Added 0.38%	100,812 $2.4 Million
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $134 - $218	8 Added 0.01%	100,430 $2.63 Million
Q3 2020 Nov 13, 2020	SELL	$12.46 - $19.98 $348 - $559	-28 Reduced 0.03%	100,422 $1.75 Million
Q2 2020 Aug 13, 2020	BUY	$11.0 - $18.26 $792 - $1,314	72 Added 0.07%	100,450 $1.69 Million
Q1 2020 May 14, 2020	BUY	$10.11 - $14.04 $192 - $266	19 Added 0.02%	100,378 $1.19 Million
Q4 2019 Feb 11, 2020	SELL	$12.06 - $16.96 $60 - $84	-5 Reduced -0.0%	100,359 $1.21 Million
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $1,113 - $1,568	107 Added 0.11%	100,364 $1.42 Million
Q2 2019 Aug 16, 2019	BUY	$9.78 - $12.76 $980,513 - $1.28 Million	100,257 New	100,257 $1.12 Million

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.27B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Corcept Therapeutics Inc Transaction History